Healthcare Equipment and Supplies
Company Overview of Baxter Healthcare Corporation
Baxter Healthcare Corporation develops, manufactures, and markets healthcare equipment and instruments. It focuses on critical therapies for life-threatening conditions, specifically with products and services in blood therapies, cardiovascular medicine, medication delivery, and renal therapy. The company offers its products in the United States and internationally. The company was formerly known as Travenol Laboratories, Inc. and changed its name to Baxter Healthcare Corporation in July 1987. The company was incorporated in 1966 and is based in Deerfield, Illinois. Baxter Healthcare Corporation operates as a subsidiary of Baxter International Inc.
One Baxter Parkway
Deerfield, IL 60015-4633
Founded in 1966
Key Executives for Baxter Healthcare Corporation
Chief Executive Officer, President, and Chairman
Compensation as of Fiscal Year 2015.
Baxter Healthcare Corporation Key Developments
Baxter Healthcare Corporation Wins $42.81 Million Federal Contract
Oct 10 15
Baxter Healthcare Corporation won a $42,812,180.55 federal contract from the U.S. Department of Veterans Affairs for cyclophosphamide injection vials for the VA National Acquisition Center, Hines, Illinois.
Rockwell Medical, Inc. Signs an Exclusive Agreement with Baxter Healthcare Corporation
Oct 3 14
Rockwell Medical, Inc. signed an exclusive agreement with Baxter Healthcare Corporation, to commercialize Rockwell's hemodialysis concentrate product line in the U.S. and in select overseas markets. Under the terms of the agreement, Baxter will become the exclusive distributor of Rockwell's hemodialysis concentrate and ancillary products in the U.S. and selected foreign countries for an initial term of 10 years. Baxter can extend the agreement for two additional 5-year terms upon meeting certain sales targets, coupled with a $7.5 million payment related to the first extension. Baxter will purchase products from Rockwell at a pre-determined gross margin-based price per unit and is required to meet minimum annual purchase levels in order to retain their exclusive rights. Baxter will leverage Rockwell's unique distribution operations in order to provide specialized customer and delivery service for concentrates, covering Rockwell's costs for these services. Rockwell will retain sales, marketing and distribution rights for its hemodialysis concentrate products in certain foreign countries in which it has an established commercial presence.
Baxter Healthcare Corporation Announces Signing of New Lease to Establish New Global Innovation and Research and Development Center
Sep 29 14
BioMed Realty Trust Inc. announced the signing of a new lease for approximately 200,000 square feet for 12 years with Baxter Healthcare Corporation at 650 East Kendall Street in Cambridge, Massachusetts. Baxter will be establishing a new global innovation and research and development (R&D) center at the site for its biopharmaceuticals business, which is expected to become a separate, independent global company known as Baxalta Incorporated in mid-2015.
Similar Private Companies By Industry
Recent Private Companies Transactions